Literature DB >> 21172598

Occurrence of atrial fibrillation during dobutamine stress echocardiography: incidence, risk factors, and outcomes.

Seth H Sheldon1, J Wells Askew, Kyle W Klarich, Christopher G Scott, Patricia A Pellikka, Robert B McCully.   

Abstract

BACKGROUND: The reported incidence of atrial fibrillation (AF) occurring during dobutamine stress echocardiography (DSE) ranges from 0.5% to 4%. The aim of this study was to characterize the incidence, risk factors, and outcomes of AF precipitated during DSE.
METHODS: The clinical and echocardiographic data of consecutive patients over a 50-month period who were in sinus rhythm and underwent DSE were retrospectively reviewed.
RESULTS: A total of 11,806 consecutive patients underwent DSE and met all inclusion criteria. AF developed during DSE in 122 patients (1%), 71 of whom had histories of AF. The duration of AF was <1 hour in 74 patients (61%) and<24 hours in 117 patients (96%). Of the 47 patients who were still in AF when dismissed from the echocardiography laboratory, 21 had outpatient follow-up within 24 hours, eight were already inpatients, and 18 were triaged to the emergency department or hospital. Spontaneous cardioversion occurred in 114 patients (93%). There were no reported complications. The clinical characteristic most strongly associated with the development of AF during DSE was a history of AF (odds ratio, 18.4 if no history of congestive heart failure; P<.001). The presence or extent of stress-induced myocardial ischemia was not predictive of the development of AF.
CONCLUSIONS: AF is an infrequent complication of DSE. Most patients return to sinus rhythm spontaneously within 1 hour. Patients with persistent AF can be safely dismissed from the echocardiography laboratory to have outpatient follow-up within 24 hours unless they have suboptimal heart rate control, hypotension, significant symptoms, or markedly abnormal findings on DSE.
Copyright © 2011 American Society of Echocardiography. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21172598     DOI: 10.1016/j.echo.2010.10.008

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  4 in total

Review 1.  Serious and potentially life threatening complications of cardiac stress testing: Physiological mechanisms and management strategies.

Authors:  Vasken Dilsizian; Henry Gewirtz; Nicholas Paivanas; Anastasia N Kitsiou; Fadi G Hage; Nathan E Crone; Ronald G Schwartz
Journal:  J Nucl Cardiol       Date:  2015-05-15       Impact factor: 5.952

2.  A Newly Defined CHA2DS2-VA Score for Predicting Obstructive Coronary Artery Disease in Patients with Atrial Fibrillation-A Cross-Sectional Study of Older Persons Referred for Elective Coronary Angiography.

Authors:  Zyta Beata Wojszel; Łukasz Kuźma; Ewelina Rogalska; Anna Kurasz; Sławomir Dobrzycki; Bożena Sobkowicz; Anna Tomaszuk-Kazberuk
Journal:  J Clin Med       Date:  2022-06-16       Impact factor: 4.964

Review 3.  Drug-induced atrial fibrillation.

Authors:  Yaman Kaakeh; Brian R Overholser; John C Lopshire; James E Tisdale
Journal:  Drugs       Date:  2012-08-20       Impact factor: 9.546

4.  Atrial fibrillation is a predictor of nonobstructive coronary artery disease in elective angiography in old age: a cross-sectional study in Poland and Russia.

Authors:  Ewelina Rogalska; Łukasz Kuźma; Zyta B Wojszel; Anna Kurasz; Dmitry Napalkov; Anastasiya Sokolova; Anna Tomaszuk-Kazberuk
Journal:  Aging Clin Exp Res       Date:  2021-06-11       Impact factor: 3.636

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.